GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients
Brand(s)
Last updated
Summary
Product
GHK-Cu & BPC-157 powder
Issue
Health products - Product quality
What to do
Consult your healthcare provider if you have any health concerns.
Distribution
National
Affected products
| Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|
| GHK-Cu (5g & 50g) | N/A | Powder | N/A | 73417, 73609, 73926, 73927 & 74120 |
| BPC-157 (5g & 50g) | N/A | Powder | N/A | 73358, 73580, 74118 & 74119 |
Issue
Products sold are unauthorized active pharmaceutical ingredients (APIs).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Compounding pharmacies
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Xenex Laboratories Inc.
2440 Conoe Ave.
Coquitlam, BC
V3K 6C2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Recall date
Identification number
RA-82047
Get notified
Receive emails about new and updated recall and safety alerts.